170 related articles for article (PubMed ID: 15671385)
1. Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls.
Kapoor V; Fukui MB; McCook BM
AJR Am J Roentgenol; 2005 Feb; 184(2):589-97. PubMed ID: 15671385
[No Abstract] [Full Text] [Related]
2. Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging.
Kapoor V; Fukui MB; McCook BM
AJR Am J Roentgenol; 2005 Feb; 184(2):579-87. PubMed ID: 15671384
[No Abstract] [Full Text] [Related]
3. A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):748-52. PubMed ID: 22911297
[No Abstract] [Full Text] [Related]
4. A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Zollinger LV; Wiggins RH
Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):754-8. PubMed ID: 22911298
[No Abstract] [Full Text] [Related]
5. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
Hanasono MM; Kunda LD; Segall GM; Ku GH; Terris DJ
Laryngoscope; 1999 Jun; 109(6):880-5. PubMed ID: 10369275
[TBL] [Abstract][Full Text] [Related]
6. Role of PET FDG in the management of head and neck squamous cell cancer.
Wong WL; Saunders M
Clin Oncol (R Coll Radiol); 1998; 10(6):361-6. PubMed ID: 9890536
[No Abstract] [Full Text] [Related]
7. Investigation of thyroid, head, and neck cancers with PET.
Zhuang H; Kumar R; Mandel S; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1101-11, viii. PubMed ID: 15488560
[TBL] [Abstract][Full Text] [Related]
8. FDG PET imaging of head and neck cancers.
Menda Y; Graham MM
Methods Mol Biol; 2011; 727():21-31. PubMed ID: 21331926
[TBL] [Abstract][Full Text] [Related]
9. Role of PET/CT in maxillo-facial surgery.
Wong WL; Batty V
Br J Oral Maxillofac Surg; 2009 Jun; 47(4):259-67. PubMed ID: 19200626
[TBL] [Abstract][Full Text] [Related]
10. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Périé S; Hugentobler A; Susini B; Balogova S; Grahek D; Kerrou K; Montravers F; Chater PE; St Guily JL; Talbot JN
Otolaryngol Head Neck Surg; 2007 Oct; 137(4):647-53. PubMed ID: 17903585
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
12. The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
Manolidis S; Donald PJ; Volk P; Pounds TR
Acta Otolaryngol Suppl; 1998; 534():1-11. PubMed ID: 9726577
[No Abstract] [Full Text] [Related]
13. PET in face and neck tumours.
Rankin SC
Cancer Imaging; 2006 Oct; 6(Spec No A):S89-95. PubMed ID: 17114083
[TBL] [Abstract][Full Text] [Related]
14. [The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
Schneider K; Aschoff P; Bihl H; Hagen R
Laryngorhinootologie; 2006 Mar; 85(3):179-83. PubMed ID: 16547893
[TBL] [Abstract][Full Text] [Related]
15. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
[TBL] [Abstract][Full Text] [Related]
16. [Positron emission tomography in head and neck oncology: five cases].
Courtois A; Foehrenbach H; Maszelin P; De Dreuille O; Garcia D; Kossowski M; Merlet P; Gaillard JF; Poncet JL
Ann Otolaryngol Chir Cervicofac; 2001 Sep; 118(4):254-60. PubMed ID: 11679846
[TBL] [Abstract][Full Text] [Related]
17. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.
Andrade RS; Heron DE; Degirmenci B; Filho PA; Branstetter BF; Seethala RR; Ferris RL; Avril N
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1315-22. PubMed ID: 16750327
[TBL] [Abstract][Full Text] [Related]
18. Advanced head and neck cancer: is there a role for fluorodeoxyglucose PET/computed tomography?
Wong WL; Nutting C; Dunn J; Fisher S; MacLennan K; MacCabe C; Mehanna H
Nucl Med Commun; 2009 Jan; 30(1):2-4. PubMed ID: 19306509
[No Abstract] [Full Text] [Related]
19. FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
Schwartz DL; Macapinlac HA; Weber RS
J Natl Cancer Inst; 2008 May; 100(10):688-9. PubMed ID: 18477798
[No Abstract] [Full Text] [Related]
20. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
